About MBA Pharmaceuticals
MBA Pharmaceuticals is a company based in India founded in 2014. MBA Pharmaceuticals offers products and services including Pharmaceutical Products and Surgical Products.
- Annual Revenue₹18.48 Cr
FY 2024 · -15% YoY
- Net Profit₹84,417
FY 2024 · 0% margin
- EBITDA₹28.3 Lakh
FY 2024 · 2% margin
Associated legal entities of MBA Pharmaceuticals
MBA Pharmaceuticals operates through Mba Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mba Pharmaceuticals Private Limited CIN U51397DL2014PTC265441 | Active | 26 Feb 2014 | New Delhi, Delhi | ₹18.5 Cr | – | 2 | View details |
Products & Services of MBA Pharmaceuticals
MBA Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Surgical Products.
Manufacturing and exporting of pharmaceutical dosages are handled to meet global healthcare needs
Distribution of surgical items is conducted alongside other offerings to support healthcare requirements
Apps and channels of MBA Pharmaceuticals
its YouTube channel MBA Pharmaceuticals Pvt Ltd has 3 subscribers and 1 videos.
Videos from MBA Pharmaceuticals
The most watched videos on MBA Pharmaceuticals's YouTube channel, MBA Pharmaceuticals Pvt Ltd (3 subscribers). Click a video to play it here.
More on MBA Pharmaceuticals Pvt Ltd.
Board of directors of Mba Pharmaceuticals Private Limited (MBA Pharmaceuticals)
Mba Pharmaceuticals Private Limited is the primary company behind MBA Pharmaceuticals. The board of Mba Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jitender Kumar, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jitender Kumar DIN 05331708 | Director | 26 Feb 2014 | 12 yrs 7 mo | Mba Pharmaceuticals Private Limited |
| Girish Kalra DIN 05331713 | Director | 26 Feb 2014 | 12 yrs 7 mo | Mba Pharmaceuticals Private Limited |
Financials of MBA Pharmaceuticals
Figures of Mba Pharmaceuticals Private Limited, the primary company behind MBA Pharmaceuticals, for FY 2024. Revenue was ₹18.48 Cr (-15% year on year). Net profit was ₹84,417 (0% margin). EBITDA was ₹28.3 Lakh (2% margin). Revenue has grown at a compounded annual rate of +5% over three years and -6% over five years.
- ₹18.48 CrRevenue · FY 2024 · -15% YoY
- ₹84,417Net profit · 0% margin
- ₹28.3 LakhEBITDA · 2% margin
- ₹20 LakhPaid-up capital
- +5%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mba Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for MBA Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to MBA Pharmaceuticals
10 companies that operate in the same segment as MBA Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MBA Pharmaceuticals
MBA Pharmaceuticals was founded in 2014.
MBA Pharmaceuticals is headquartered in India.
The primary company behind MBA Pharmaceuticals, Mba Pharmaceuticals Private Limited, reported revenue of ₹18.48 Cr for FY 2024, down 15% year on year.
MBA Pharmaceuticals is recognized as a pharmaceutical wholesale and manufacturing entity with origins in India, where operations are conducted in compliance with GDP and ISO 9001:2015 standards. It is involved in the export of medicines to over 20 countries across various regions, including Asia, the European Union, and Africa. Services such as contract manufacturing and regulatory support are provided to facilitate global product registration. Established in 2005, it focuses on delivering affordable and innovative pharmaceutical solutions, with a commitment to serving worldwide healthcare needs through qualified resources and comprehensive documentation.
MBA Pharmaceuticals offers Pharmaceutical Products and Surgical Products.
MBA Pharmaceuticals operates through Mba Pharmaceuticals Private Limited.
The legal entities of MBA Pharmaceuticals currently have 2 directors, including Jitender Kumar, Girish Kalra.